News Categories: Medical Marijuana

May 2019

New Steps to Advance FDA’s Evaluation of CBD

The Food and Drug Administration (FDA) is moving forward with evaluating ways to allow cannabis and cannabis-derived products like cannabidiol (CBD) into foods, beverages, and dietary supplements. A public hearing

November 2017

Cannabis Licenses Carry High Capitalization Costs

As has long been suspected, the state announced last week that those seeking licenses from the Michigan Bureau of Medical Marihuana Regulation (BMMR) beginning in December will undergo an evaluation